Barclays PLC Has $24.79 Million Stock Holdings in Mineralys Therapeutics, Inc. $MLYS

Barclays PLC boosted its holdings in shares of Mineralys Therapeutics, Inc. (NASDAQ: MLYS) by 354.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 653,830 shares of the company's stock after acquiring an additional 509,946 shares during the quarter. Barclays PLC